AI Terminal
Pharmanutra
Remuneration Information • Apr 1, 2021
4324_def-14a_2021-04-01_fe37ff9f-55ce-41e9-a857-2935338d547d.pdf
Remuneration Information
Open in ViewerOpens in native device viewer
| Informazione Regolamentata n. 20106-16-2021 |
Data/Ora Ricezione 01 Aprile 2021 18:09:17 |
MTA - Star | |
|---|---|---|---|
| Societa' | : | Pharmanutra S.p.A. | |
| Identificativo Informazione Regolamentata |
: | 144726 | |
| Nome utilizzatore | : | PHARMANUTRAN02 - Lacorte Roberto | |
| Tipologia | : | REGEM | |
| Data/Ora Ricezione | : | 01 Aprile 2021 18:09:17 | |
| Data/Ora Inizio Diffusione presunta |
: | 01 Aprile 2021 18:09:18 | |
| Oggetto | : | PR - PHARMANUTRA SPA Filing report on remuneration policy 2020 |
|
| Testo del comunicato |
Vedi allegato.
PHARMANUTRA S.P.A.: FILING OF THE REPORT ONTHE REMUNERATIONPOLICY
Pisa, 1 st April 2021 – PharmaNutra S.p.A. announces that the Report on the remuneration policy and the remuneration paid is available in the registered office in Pisa, via delle Lenze 216/b, on the Company website www.pharmanutra.it, in section Governance/Shareholders' Meeting and in the authorised storage mechanism "eMarket Storage" on the website .
PharmaNutra S.p.A.
Founded and led by the President Andrea Lacorte and Vice President Roberto Lacorte, PharmaNutra was established in 2003. It develops unique nutritional supplements and innovative medical devices, handling the entire production process, from proprietary raw materials to finished product. The efficacy of the products has been demonstrated with a wealth of scientific evidence. The Group distributes and sells its products in Italy and abroad. In Italy, products are sold through a network of 150 Pharmaceutical Representatives serving doctors and also exclusively selling PharmaNutra products to pharmacies throughout Italy. Products are sold in over 50 countries abroad, through 39 partners selected from among the finest pharmaceutical companies. PharmaNutra leads the market in the production of iron-based nutritional supplements under the SiderAL® brand, where it boasts a number of important patents on Sucrosomial® technology. Over the years, the Group has developed a precise strategy for the management and production of intellectual property, founded on the integrated management of all the various elements: proprietary raw materials, patents, brands and clinical evidence. PharmaNutra.it
For further information:
Via Delle Lenze, 216/b - 56122 Pisa Tel. +39 050 7846500 [email protected]
Internal Press Office [email protected]
PharmaNutra S.p.A. Press Office - Spriano Communication & Partners
Via Santa Radegonda, 16 - 20121 Milan Tel. +39 02 83635708
Matteo Russo [email protected] Cristina Tronconi [email protected]
